I was fortunate enough to be awarded the BSGCT travel grant to attend the BSGCT annual conference held between the 17-19th June 2024 in Oxford. The event took place in the SaΪd business school, a perfect location, just a stones…
The BSGCT Conference celebrated the path of research that led to today’s ground-breaking treatments. As scientists from around the world descended on London last month to discuss monumental advances in gene and cell therapy research, it is befitting to reflect…
Author: Dr. Rebecca A Lea, University of Sheffield Charcot-Marie-Tooth (CMT) disease is an umbrella term that encompasses a broad range of genetic neurodegenerative diseases, first described by doctors in 1886 [1, 2]. It is characterised by symptoms such as muscle…
Expression of interest: Prosperity partnerships: advanced therapies safety and toxicity Opportunity status: Open Funders: Medical Research Council (MRC) Funding type: Grant Total fund: £10,500,000 Award range: £2,000,000 - £4,000,000 Publication date: 30 August 2024 Opening date: 30 August 2024 9:00am…
This month’s ‘researcher in the spotlight’ is BSGCT mentee, Alexandros Angelopoulos, Northumbria University. Can you tell us about your research or your studies in the field? I am a BSc student at Northumbria University, Newcastle currently undertaking a project investigating…